Bayview Legacy files Form 144 to resell 700,000 shares

Bayview Legacy, LLC reported proposed resale of 700,000 shares of Common Stock, acquired 11/05/2013, on Nasdaq.

Rhea-AI Filing Summary

Bayview Legacy, LLC reported proposed resale of 700,000 shares of Common Stock, acquired 11/05/2013, on Nasdaq. The filing lists recent automated sales executed under a 10b5-1 plan: 70,000 shares sold on each of 04/08/2026, 05/08/2026, and 06/08/2026, with proceeds of $1,332,782, $2,183,986, and $2,443,434, respectively.

Shares outstanding are shown as 46,171,982 as of 07/01/2026. The resale is described as a private acquisition from the issuer or an affiliate, and transactions were effected pursuant to a 10b5-1 plan per the sales entries.

Insights

Securities Attorney

Rule 144 resale filing documents a planned resale of restricted shares and recent 10b5-1 executions.

The filing shows a resale of 700,000 shares acquired on 11/05/2013 and three executed 10b5-1 sales of 70,000 shares each in April–June 2026. The filing language identifies the acquisition source as a "Private Acquisition from Issuer or an Affiliate."

Key compliance items to note: ensure volume limitations and any holding-period requirements under Rule 144 were met given the acquisition date; timing and method of future sales are governed by the 10b5-1 plan terms. Cash‑flow treatment is the selling holder’s proceeds from resale.

Equity Capital Markets Analyst

Representative selling activity shows staged dispositions under an automated plan, modest relative to the outstanding share count.

The excerpt lists recent 10b5-1 sales totaling 210,000 shares over three months and a prospective 700,000-share resale filing. Shares outstanding are reported as 46,171,982 as of 07/01/2026, providing scale for potential overhang.

Actual market impact depends on subsequent holder decisions and execution method; future filings will clarify whether remaining planned sales are incremental to these 10b5-1 trades.

Key Figures

Shares proposed for resale: 700,000 shares 10b5-1 sale (Apr 8 2026): 70,000 shares 10b5-1 sale (May 8 2026): 70,000 shares +2 more

5 metrics

Shares proposed for resale 700,000 shares acquired 11/05/2013

10b5-1 sale (Apr 8 2026) 70,000 shares proceeds $1,332,782 on 04/08/2026

10b5-1 sale (May 8 2026) 70,000 shares proceeds $2,183,986 on 05/08/2026

10b5-1 sale (Jun 8 2026) 70,000 shares proceeds $2,443,434 on 06/08/2026

Shares outstanding 46,171,982 shares as of 07/01/2026

Key Terms

10b5-1, Private Acquisition from Issuer or an Affiliate, Form 144

3 terms

10b5-1 regulatory

"10b5-1 Sales for BAYVIEW LEGACY, LLC 900 E. Hamilton Ave."

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

Private Acquisition from Issuer or an Affiliate transactional

"Private Acquisition from Issuer or an Affiliate | Issuer"

Form 144 regulatory

"Filer Information | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Bayview Legacy, LLC's Form 144 say about the number of shares for resale?

The Form 144 lists a proposed resale of 700,000 shares of Common Stock, acquired on 11/05/2013. This is the amount identified in the filing as the securities to be sold.

Which recent 10b5-1 sales by Bayview Legacy, LLC are reported in the filing?

The filing reports three 10b5-1 sales of 70,000 shares each on 04/08/2026, 05/08/2026, and 06/08/2026, with proceeds of $1,332,782, $2,183,986, and $2,443,434, respectively.

What acquisition source is listed for the shares Bayview Legacy intends to sell?

The filing identifies the shares as a "Private Acquisition from Issuer or an Affiliate", with the acquisition date shown as 11/05/2013 in the securities-to-be-sold section.

On which exchange are the shares listed according to the excerpt?

The excerpt shows the security trading venue as NASDAQ and provides an outstanding-share figure of 46,171,982 as of 07/01/2026 for context.

Do the reported transactions indicate how proceeds are treated?

Proceeds shown correspond to the selling holder's 10b5-1 sales ($1,332,782, $2,183,986, $2,443,434); the filing does not allocate proceeds to the issuer. Cash‑flow treatment is the selling holder’s proceeds.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/01/2026 - 05:00 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001888862
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ARTERIS, INC.
SEC File Number	001-40960
Address of Issuer	900 E. Hamilton Ave., Suite 300 Campbell CALIFORNIA 95008
Phone	4084707300
Name of Person for Whose Account the Securities are To Be Sold	BAYVIEW LEGACY, LLC
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	10% Stockholder

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	700000	34013000.00	46171982	07/01/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/05/2013	Private Acquisition from Issuer or an Affiliate	Issuer			700000	11/05/2013	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for BAYVIEW LEGACY, LLC 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	06/08/2026	70000	2443434.00
10b5-1 Sales for BAYVIEW LEGACY, LLC 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	05/08/2026	70000	2183986.00
10b5-1 Sales for BAYVIEW LEGACY, LLC 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	04/08/2026	70000	1332782.00

144: Remarks and Signature

Remarks
Date of Notice	07/01/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	12/12/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Karel Charles Janac
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)